Xenon Pharmaceuticals Inc. ($XENE)
Filing Information
| Accession Number | 0001193125-26-106727 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 14, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
8,910
Total Value
$77,867.25
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Shares | โ | Mar 12, 2026 | Exercise/Conversion | 3,750 | โ | โ | 8,479 | Direct | โ | View Details | |
Chief Medical Officer | Common Shares | โ | Mar 13, 2026 | Sale | 1,410 | $55.23 | $77,867.25 | 7,069 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Share Units | Derivative | Mar 12, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 11,250 | Direct | โ | View Details |